<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Studies of lymphoid <z:hpo ids='HP_0002664'>neoplasms</z:hpo> occurring in <z:mpath ids='MPATH_458'>normal</z:mpath> or genetically engineered mice have revealed parallels and differences to non-Hodgkin <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (NHL) of humans </plain></SENT>
<SENT sid="1" pm="."><plain>Some mouse <z:hpo ids='HP_0002665'>lymphomas</z:hpo> have strong histologic similarities to the human NHL subsets including precursor B- and T-cell lymphoblastic, small lymphocytic, splenic marginal zone, and diffuse large-cell B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (DLCL); whether molecular parallels also exist is under study </plain></SENT>
<SENT sid="2" pm="."><plain>Others mouse types such as sIg+ lymphoblastic B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> have no histologic equivalent in human NHL even though they share molecular deregulation of BCL6 with human DLCL </plain></SENT>
<SENT sid="3" pm="."><plain>Finally, Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> does not appear to occur naturally in mice, but it can be induced with appropriately engineered transgenes </plain></SENT>
</text></document>